PL1730299T3 - Zestaw do pomiaru generacji trombiny w próbce krwi lub osocza pacjenta - Google Patents
Zestaw do pomiaru generacji trombiny w próbce krwi lub osocza pacjentaInfo
- Publication number
- PL1730299T3 PL1730299T3 PL05729048T PL05729048T PL1730299T3 PL 1730299 T3 PL1730299 T3 PL 1730299T3 PL 05729048 T PL05729048 T PL 05729048T PL 05729048 T PL05729048 T PL 05729048T PL 1730299 T3 PL1730299 T3 PL 1730299T3
- Authority
- PL
- Poland
- Prior art keywords
- kit
- sample
- patient
- thrombin generation
- measuring
- Prior art date
Links
- 108090000190 Thrombin Proteins 0.000 title abstract 4
- 229960004072 thrombin Drugs 0.000 title abstract 4
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 2
- 239000003114 blood coagulation factor Substances 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- 108010000499 Thromboplastin Proteins 0.000 abstract 1
- 102000002262 Thromboplastin Human genes 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 235000011148 calcium chloride Nutrition 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000301 factor viii Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/816,099 US20050221414A1 (en) | 2004-03-31 | 2004-03-31 | Kit for measuring the thrombin generation in a sample of a patient's blood or plasma |
| PCT/EP2005/003328 WO2005095638A2 (en) | 2004-03-31 | 2005-03-30 | A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma |
| EP05729048A EP1730299B1 (en) | 2004-03-31 | 2005-03-30 | A kit for measuring the thrombin generation in a sample of a patient's blood or plasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1730299T3 true PL1730299T3 (pl) | 2011-10-31 |
Family
ID=34963198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05729048T PL1730299T3 (pl) | 2004-03-31 | 2005-03-30 | Zestaw do pomiaru generacji trombiny w próbce krwi lub osocza pacjenta |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20050221414A1 (pl) |
| EP (1) | EP1730299B1 (pl) |
| JP (1) | JP4620726B2 (pl) |
| AT (1) | ATE511549T1 (pl) |
| AU (1) | AU2005229408B2 (pl) |
| CA (1) | CA2558928A1 (pl) |
| ES (1) | ES2367439T3 (pl) |
| PL (1) | PL1730299T3 (pl) |
| RU (1) | RU2360970C2 (pl) |
| WO (1) | WO2005095638A2 (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235377B2 (en) * | 2003-06-09 | 2007-06-26 | The University Of Vermont And State Agriculture College | Global test of the hemostatic system |
| US7932021B2 (en) * | 2005-07-28 | 2011-04-26 | American Diagnostica, Inc. | Lupus anticoagulant testing |
| EP1920068A4 (en) * | 2005-07-28 | 2008-08-13 | American Diagnostica Inc | LUPIC ANTICOAGULANT TEST |
| EP1966389B1 (en) | 2005-12-27 | 2019-07-10 | McMASTER UNIVERSITY | Enzyme measurement assay using a modified substrate comprising a substrate attached to a macromolecule via a spacer |
| US9091700B2 (en) | 2005-12-27 | 2015-07-28 | Mcmaster University | Modified peptide substrate |
| FR2978163B1 (fr) * | 2011-07-22 | 2013-08-30 | Stago Diagnostica | Utilisation d'un substrat dans une methode pour mesurer l'activite des enzymes proteolytiques disponibles |
| FR2978164B1 (fr) * | 2011-07-22 | 2013-08-30 | Stago Diagnostica | Utilisation d'un substrat dans une methode pour mesurer l'activite des enzymes proteolytiques |
| KR101383333B1 (ko) * | 2012-01-13 | 2014-04-10 | 연세대학교 산학협력단 | 트롬빈 생성 측정 방법 |
| US10266871B2 (en) | 2012-12-18 | 2019-04-23 | Daiichi Sankyo Company, Limited | Measurement method for thrombin production |
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| EA028016B1 (ru) * | 2013-06-06 | 2017-09-29 | Общество с ограниченной ответственностью "Гематологическая Корпорация" (ООО "ГемаКор") | Набор для измерения параметров системы гемостаза в образце крови или ее компонентов |
| WO2016196207A1 (en) | 2015-05-29 | 2016-12-08 | Water Lens, Llc. | Compositions, apparatus, and methods for determining hardness of water and magnesium ion in an analyte composition |
| JP6626761B2 (ja) * | 2016-03-30 | 2019-12-25 | シスメックス株式会社 | プロトロンビン時間測定用試薬およびその製造方法 |
| US11136370B2 (en) | 2016-05-13 | 2021-10-05 | The Scripps Research Institute | Compositions and methods for thrombin generation assay |
| RU177920U1 (ru) * | 2016-11-30 | 2018-03-15 | Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") | Устройство мониторинга пространственно-временной динамики тромбина |
| EP3363912B1 (en) * | 2017-02-17 | 2020-10-28 | Synapse B.V. | Self-calibrated assay for determining proteolytic enzyme generation, dedicated means and uses thereof |
| CN107796793B (zh) * | 2017-09-28 | 2020-04-10 | 中国科学技术大学 | FXa的检测试剂及检测方法 |
| CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
| JP7653013B2 (ja) | 2018-01-04 | 2025-03-28 | アイコニック セラピューティクス リミテッド ライアビリティ カンパニー | 抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法 |
| WO2020185916A1 (en) | 2019-03-14 | 2020-09-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
| CN110208552A (zh) * | 2019-05-22 | 2019-09-06 | 深圳市国赛生物技术有限公司 | 凝血酶时间检测试剂及其制备方法 |
| CN110412001B (zh) * | 2019-08-01 | 2022-02-11 | 武汉塞力斯生物技术有限公司 | 一种动态监测凝血酶生成能力的试剂盒 |
| WO2022011323A1 (en) * | 2020-07-10 | 2022-01-13 | Iconic Therapeutics, Inc. | Ocular disease treatment using anti-tissue factor antibodies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3516579A1 (de) * | 1984-11-19 | 1986-05-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Gerinnungstest auf teststreifen |
| US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
| US5314695A (en) | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
| ATE163768T1 (de) * | 1991-10-04 | 1998-03-15 | Dade Int Inc | Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden |
| AT397391B (de) * | 1992-05-15 | 1994-03-25 | Immuno Ag | Verwendung von prothrombinfragmenten |
| US6387881B1 (en) * | 1992-09-19 | 2002-05-14 | Trigen Ltd | Inhibitors and substrates of thrombin |
| US5418141A (en) * | 1994-05-06 | 1995-05-23 | Avocet Medical, Inc. | Test articles for performing dry reagent prothrombin time assays |
| CA2209991C (en) * | 1995-01-19 | 2005-04-12 | Gen-Probe Incorporated | Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia |
| US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| CA2286164A1 (en) * | 1997-04-09 | 1998-10-15 | Gunter Wober | Method for determining activated coagulation factors in plasma and plasma derivatives |
| DE69832628T2 (de) * | 1997-04-23 | 2006-09-07 | Instrumentation Laboratory S.P.A. | Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz |
| DE19749197A1 (de) * | 1997-11-07 | 1999-05-12 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe |
| US6756019B1 (en) * | 1998-02-24 | 2004-06-29 | Caliper Technologies Corp. | Microfluidic devices and systems incorporating cover layers |
| US6713506B2 (en) * | 2000-10-11 | 2004-03-30 | University Of South Florida | Tea polyphenol esters and analogs thereof for cancer prevention and treatment |
| US6576422B1 (en) * | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
| US6844149B2 (en) * | 2001-06-29 | 2005-01-18 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
-
2004
- 2004-03-31 US US10/816,099 patent/US20050221414A1/en not_active Abandoned
-
2005
- 2005-03-30 AT AT05729048T patent/ATE511549T1/de active
- 2005-03-30 JP JP2007505490A patent/JP4620726B2/ja not_active Expired - Lifetime
- 2005-03-30 RU RU2006138237/13A patent/RU2360970C2/ru active
- 2005-03-30 PL PL05729048T patent/PL1730299T3/pl unknown
- 2005-03-30 EP EP05729048A patent/EP1730299B1/en not_active Expired - Lifetime
- 2005-03-30 AU AU2005229408A patent/AU2005229408B2/en not_active Expired
- 2005-03-30 WO PCT/EP2005/003328 patent/WO2005095638A2/en not_active Ceased
- 2005-03-30 ES ES05729048T patent/ES2367439T3/es not_active Expired - Lifetime
- 2005-03-30 CA CA002558928A patent/CA2558928A1/en not_active Abandoned
-
2012
- 2012-06-29 US US13/539,154 patent/US8735086B2/en not_active Expired - Lifetime
-
2014
- 2014-04-25 US US14/261,608 patent/US20140232029A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2558928A1 (en) | 2005-10-13 |
| EP1730299B1 (en) | 2011-06-01 |
| US20130052672A1 (en) | 2013-02-28 |
| ES2367439T3 (es) | 2011-11-03 |
| RU2360970C2 (ru) | 2009-07-10 |
| WO2005095638B1 (en) | 2006-11-02 |
| ATE511549T1 (de) | 2011-06-15 |
| US20140232029A1 (en) | 2014-08-21 |
| AU2005229408A1 (en) | 2005-10-13 |
| JP4620726B2 (ja) | 2011-01-26 |
| EP1730299A2 (en) | 2006-12-13 |
| US20050221414A1 (en) | 2005-10-06 |
| RU2006138237A (ru) | 2008-05-10 |
| WO2005095638A2 (en) | 2005-10-13 |
| AU2005229408B2 (en) | 2009-06-11 |
| US8735086B2 (en) | 2014-05-27 |
| WO2005095638A3 (en) | 2006-03-02 |
| JP2007530963A (ja) | 2007-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005095638A3 (en) | A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma | |
| DE69920940D1 (de) | Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte | |
| WO2001082793A3 (en) | Method and device for testing a sample of fresh whole blood | |
| WO2008092644A3 (en) | Fviii-independent fix-mutant proteins for hemophilia a treatment | |
| ATE268477T1 (de) | Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit | |
| HUP0105077A2 (hu) | Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| WO2005012337A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
| WO2004111081A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
| WO2007106142A3 (en) | Process for using optical agents | |
| Bretschneider et al. | Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells | |
| WO2007106893A3 (en) | Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors | |
| WO2005118836A3 (en) | Hif prolyl hydroxylase activity assay | |
| Shenkman et al. | The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model | |
| Salem et al. | Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro. | |
| ATE529743T1 (de) | Verfahren und kits zur tumorigenizitätsdiagnose | |
| Pabinger-Fasching et al. | High levels of plasma protein C in nephrotic syndrome | |
| SE8501614L (sv) | Solubiliserbar, fibrinbaserad komposition och anvendning derav | |
| ATE395603T1 (de) | Reagenziensatz zum nachweis von lupus- antikoagulant. | |
| WO2006124866A3 (en) | Free human serum ige immunoenzymetric assay and methods of use | |
| CN110412001A (zh) | 一种动态监测凝血酶生成能力的试剂盒 | |
| WO2001016355A3 (de) | In-vitro-testsystem für gamma-sekretase aus angereicherten-membranen | |
| Jones et al. | The crystal growth technique-a laboratory evaluation of bond strengths | |
| DE50203415D1 (de) | Verfahren zur vorhersage eines transplantatabstossungsrisikos und immunologischer testkit | |
| Bajusz et al. | Active site-directed thrombin inhibitors: α-hydroxyacylprolyl-arginals. New orally active stable analogs of d-Phe-Pro-Arg-H | |
| Ioannidou-Papayannaki et al. | Alterations in the fibrinolytic system components during acute myocardial infarction |